Livzon Pharmaceutical Group ( (HK:1513) ) has issued an update.
Livzon Pharmaceutical Group Inc. announced the resignation of Mr. Yang Daihong from his position as vice president due to a work adjustment. Despite his resignation, Mr. Yang will continue to hold other roles within the company, and his departure is not expected to impact the company’s operations. The board expressed gratitude for Mr. Yang’s diligent service during his tenure.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the development and production of medical products and services.
YTD Price Performance: -0.29%
Technical Sentiment Signal: Buy
Current Market Cap: $3.93B
See more insights into 1513 stock on TipRanks’ Stock Analysis page.